IU School of Medicine

Elective Title: 93FR910 — PHARMACEUTICAL DEVELOPMENT MEDICAL STUDENT ELECTIVE

Description:

The Medical Student Elective Rotation Program at Eli Lilly and Company is an experiential learning program designed for third and fourth year medical students. The four-week program will provide an enriching educational opportunity at Lilly's corporate headquarters in Indianapolis, Indiana. Participants will receive hands-on experience and knowledge of the pharmaceutical industry by exploring the various phases of drug development including research, clinical trial development, regulatory, bioethics, and patient safety. Additionally, students will learn of the many physician and health care provider roles in an industrial setting. Students will work with an assigned preceptor responsible for planning their curriculum during each elective rotation.

Elective Details:

Primary Contact for Add/Drops: Dr. Jennelle Durnett Richardson (jdrichar@iupui.edu)

Director: Brad Woodward, M.D., M.B.A.

Campus: Indianapolis

Location: Eli Lilly and Company (Indianapolis)

Other Faculty: Students will be assigned a physician preceptor, yet will work in teams with other employees and health care providers including pharmacists, scientists, and nurses.

Learning Objectives

  • 1) Identify the various phases of the drug development process (MK5)
  • 2) Develop and enhance knowledge of the pharmaceutical industry and its place in the practice of medicine (PBLI1)
  • 3) Discuss administrative and management aspects within the pharmaceutical industry (PBLI1)
  • 4) Describe the types of physician and other health care provider roles that contribute to the drug development process (SBP1)
  • 5) Describe how the pharmaceutical industry and regulatory agencies collaborate to bring medications to patients (MK5)
  • 6) Discuss the bioethics, compliance, and legal considerations associated with drug development, including identifying and managing conflicts of interest between the pharmaceutical industry and medical practice (P3)

Assessment

  • Professional Development Evaluation Form 1. Observation of medical knowledge, learning agility, skill development, and performance 2. Interaction with Lilly employees 3. Student presentation of final project 4. Preceptor and other key stakeholder evaluations 5. Student written reflection of the learning experience that addresses each of the learning objectives above.

Enrollment Information

Prerequisites: 4th year status (at the time of the elective). To be considered for this elective, students must submit all application materials. Selected students must be able to show proof they can legally work in the US.

Availability with Max Students per Month:

JuneJulyAugSeptOctNovDecJanFebMarAprMay
000110002220

Duty Hours: 40

Time Distribution: 50% Library/Research; 25% Laboratory; 25% Lecture/Seminar

Elective Type Category: PD - Professional Development

Notes and Enrollment Information:

Add/Drop Contact Person: Dr. Jennelle Durnett Richardson (jdrichar@iupui.edu) THIS ELECTIVE DOES NOT PARTICIPATE IN THE INITIAL SENIOR MATCH To be considered for this elective, students must submit their c.v., a brief statement of interest, and preferred month(s) to Dr. Jennelle Durnett Richardson (jdrichar@iupui.edu). Submissions will be reviewed and, if accepted, forwarded to the course director and program director for consideration in their selection process, which includes an interview and review of qualifications. Selected students are required to review the IUSM Industry Relations Conflict of Interest Policy prior to enrollment: http://medicine.iu.edu/resources/conflict-of-interest-policy-at-iusm/ Students will be classified as an unpaid contractor of Eli Lilly and Company for their 4 week elective rotation. As part of the elective rotation on-boarding process, medical students will be required to complete the following conditions, within a 30 day window, prior to their rotation start date: 1. Redbook Training : Lilly's Code of Conduct - to educate students on the pharmaceutical industry and appropriate conduct in a regulated environment. Students will learn about Lilly's policies regarding compliance, regulatory, and confidentiality as it relates to intellectual property, privacy information, clinical trial results, and overall ethics and compliance. 2. Students are required to sign a confidentiality agreement – because of the sensitive nature and confidentiality in the drug development process, students are required to sign a confidentiality disclosure so they may be exposed to information, processes, and data that is the intellectual property of Eli Lilly and Company. 3. Background Check 4. Drug Screen For students outside the Indianapolis area, please note that there is housing available during the months of April, June, August, and September.

Third Year Elective? No

Interprofessional Skills and Service Learning

Interprofessional Collaborative Skills: Yes

Skills Description: The Pharmaceutical Development Medical Student Elective (93FR910) excludes direct patient care, however it does involve exposure and collaboration to research pharmacists (eg, PharmD), visiting scientist fellows (eg, pharmacists, PhD), and research scientists (including PhD, nurses) as part of the broader work teams, 1:1 informational meetings, and networking opportunities.

Service Learning Included: None